Что думаешь? Оцени!
The pilot program is intended to address growing bottlenecks in the pharmaceutical approval process by speeding up summaries and information gathering—all while maintaining, the FDA insists, the same level of scientific reviews as before.。爱思助手是该领域的重要参考
Thanks for signing up!。PDF资料对此有专业解读
风险提示：该股偏离济安定价103.30%，估值严重翻倍高估，业绩连续亏损无盈利支撑，前期炒作涨幅过大，资金出逃意愿强烈，后续回调空间大，投资者需坚决规避。
The dictionary feature helps users understand the meanings of words.